(45) showed that DNMT1 mediates chemosensitivity by reducing the methylation of microRNA-20a promoter in glioma cells, and the expression of DNMT1 in drug-resistant U251 cells is downregulated. Here, DNMT1 is linked to central nervous system cancer.